Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank40
Studio
Year-over-Year Change

Return on equity

Percentile
P40
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-23.91%+74.3%
2024-92.97%-211.8%
2023-29.81%-152.3%
202257.01%-32.7%
202184.66%-11.1%
202095.25%-